Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Rotator CUFF disorders: A survey of current physiotherapy practice in Belgium and the Netherlands.

Pieters L, Voogt L, Bury J, Littlewood C, Feijen S, Cavaggion C, Struyf F.

Musculoskelet Sci Pract. 2019 Jun 17;43:45-51. doi: 10.1016/j.msksp.2019.06.001. [Epub ahead of print]

PMID:
31228812
2.

Differences in scapular upward rotation, pectoralis minor and levator scapulae muscle length between the symptomatic, the contralateral asymptomatic shoulder and control subjects: a cross-sectional study in a Spanish primary care setting.

Navarro-Ledesma S, Fernandez-Sanchez M, Struyf F, Martinez-Calderon J, Miguel Morales-Asencio J, Luque-Suarez A.

BMJ Open. 2019 Jun 12;9(6):e023020. doi: 10.1136/bmjopen-2018-023020.

3.

Training volume is associated with pain sensitivity, but not with endogenous pain modulation, in competitive swimmers.

Kuppens K, Feijen S, Roussel N, Nijs J, Cras P, van Wilgen P, Struyf F.

Phys Ther Sport. 2019 May;37:150-156. doi: 10.1016/j.ptsp.2019.04.001. Epub 2019 Apr 5.

PMID:
30978601
4.

Non-traumatic chronic shoulder pain is not associated with changes in rotator cuff interval tendon thickness.

Navarro-Ledesma S, Struyf F, Falla D, Luque-Suarez A.

Clin Biomech (Bristol, Avon). 2019 Mar;63:147-152. doi: 10.1016/j.clinbiomech.2019.02.011. Epub 2019 Mar 2.

PMID:
30897462
5.

The influence of cognitions, emotions and behavioral factors on treatment outcomes in musculoskeletal shoulder pain: a systematic review.

De Baets L, Matheve T, Meeus M, Struyf F, Timmermans A.

Clin Rehabil. 2019 Jun;33(6):980-991. doi: 10.1177/0269215519831056. Epub 2019 Feb 22.

PMID:
30791696
6.

Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.

Folschweiller N, Behre U, Dionne M, Durando P, Esposito S, Ferguson L, Ferguson M, Hillemanns P, McNeil SA, Peters K, Ramjattan B, Schwarz TF, Supparatpinyo K, Suryakirian PV, Janssens M, Moris P, Decreux A, Poncelet S, Struyf F.

J Infect Dis. 2019 May 5;219(11):1799-1803. doi: 10.1093/infdis/jiy743.

7.

A Manual Therapy and Home Stretching Program in Patients With Primary Frozen Shoulder Contracture Syndrome: A Case Series.

Dueñas L, Balasch-Bernat M, Aguilar-Rodríguez M, Struyf F, Meeus M, Lluch E.

J Orthop Sports Phys Ther. 2019 Mar;49(3):192-201. doi: 10.2519/jospt.2019.8194. Epub 2019 Jan 18.

PMID:
30658049
8.

The association between pain beliefs and pain intensity and/or disability in people with shoulder pain: A systematic review.

Martinez-Calderon J, Struyf F, Meeus M, Luque-Suarez A.

Musculoskelet Sci Pract. 2018 Oct;37:29-57. doi: 10.1016/j.msksp.2018.06.010. Epub 2018 Jun 28. Review.

PMID:
29980139
9.

Intra- and interrater reliability of the 'lumbar-locked thoracic rotation test' in competitive swimmers ages 10 through 18 years.

Feijen S, Kuppens K, Tate A, Baert I, Struyf T, Struyf F.

Phys Ther Sport. 2018 Jul;32:140-144. doi: 10.1016/j.ptsp.2018.04.012. Epub 2018 Apr 17.

PMID:
29793122
10.

The role of psychological factors in the perpetuation of pain intensity and disability in people with chronic shoulder pain: a systematic review.

Martinez-Calderon J, Meeus M, Struyf F, Miguel Morales-Asencio J, Gijon-Nogueron G, Luque-Suarez A.

BMJ Open. 2018 Apr 13;8(4):e020703. doi: 10.1136/bmjopen-2017-020703.

11.

Safety and Immunogenicity of the HPV-16/18 AS04-adjuvanted Vaccine in 4-6-year-old Girls: Results to Month 12 From a Randomized Trial.

Lin L, Parra MM, Sierra VY, Cespedes AS, Granados MA, Luque A, Damaso S, Castrejon Alba MM, Romano-Mazzotti L, Struyf F.

Pediatr Infect Dis J. 2018 Apr;37(4):e93-e102. doi: 10.1097/INF.0000000000001871.

PMID:
29424799
12.

Inter- and intrarater reliability of two proprioception tests using clinical applicable measurement tools in subjects with and without knee osteoarthritis.

Baert IAC, Lluch E, Struyf T, Peeters G, Van Oosterwijck S, Tuynman J, Rufai S, Struyf F.

Musculoskelet Sci Pract. 2018 Jun;35:105-109. doi: 10.1016/j.msksp.2017.11.011. Epub 2017 Nov 21.

PMID:
29174222
13.

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial.

Leung TF, Liu AP, Lim FS, Thollot F, Oh HML, Lee BW, Rombo L, Tan NC, Rouzier R, De Simoni S, Suryakiran P, Hezareh M, Thomas F, Folschweiller N, Struyf F.

Vaccine. 2018 Jan 2;36(1):98-106. doi: 10.1016/j.vaccine.2017.11.034. Epub 2017 Nov 23.

14.

Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age.

Schwarz TF, Galaj A, Spaczynski M, Wysocki J, Kaufmann AM, Poncelet S, Suryakiran PV, Folschweiller N, Thomas F, Lin L, Struyf F.

Cancer Med. 2017 Nov;6(11):2723-2731. doi: 10.1002/cam4.1155. Epub 2017 Oct 5.

15.

Sensory processing and central pain modulation in patients with chronic shoulder pain: A case-control study.

Kuppens K, Hans G, Roussel N, Struyf F, Fransen E, Cras P, Van Wilgen CP, Nijs J.

Scand J Med Sci Sports. 2018 Mar;28(3):1183-1192. doi: 10.1111/sms.12982. Epub 2017 Oct 4.

PMID:
28980347
16.

Short stem total hip arthroplasty: Potential explanations for persistent post-surgical thigh pain.

Baert IAC, Lluch E, Van Glabbeek F, Nuyts R, Rufai S, Tuynman J, Struyf F, Meeus M.

Med Hypotheses. 2017 Sep;107:45-50. doi: 10.1016/j.mehy.2017.07.028. Epub 2017 Jul 20.

PMID:
28915961
17.

Illness Perceptions Explain the Variance in Functional Disability, but Not Habitual Physical Activity, in Patients With Chronic Low Back Pain: A Cross-Sectional Study.

Leysen M, Nijs J, Van Wilgen CP, Struyf F, Meeus M, Fransen E, Demoulin C, Smeets RJEM, Roussel NA.

Pain Pract. 2018 Apr;18(4):523-531. doi: 10.1111/papr.12642. Epub 2017 Oct 26.

PMID:
28914487
18.

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.

Lehtinen M, Lagheden C, Luostarinen T, Eriksson T, Apter D, Harjula K, Kuortti M, Natunen K, Palmroth J, Petäjä T, Pukkala E, Siitari-Mattila M, Struyf F, Nieminen P, Paavonen J, Dubin G, Dillner J.

BMJ Open. 2017 Aug 18;7(8):e015867. doi: 10.1136/bmjopen-2017-015867.

19.

Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.

Huang LM, Puthanakit T, Cheng-Hsun C, Ren-Bin T, Schwarz T, Pellegrino A, Esposito S, Frenette L, McNeil S, Durando P, Rheault P, Giaquinto C, Horn M, Petry KU, Peters K, Azhar T, Hillemanns P, De Simoni S, Friel D, Pemmaraju S, Hezareh M, Thomas F, Descamps D, Folschweiller N, Struyf F.

J Infect Dis. 2017 Jun 1;215(11):1711-1719. doi: 10.1093/infdis/jix154.

20.

Is coracohumeral distance associated with pain-function, and shoulder range of movement, in chronic anterior shoulder pain?

Navarro-Ledesma S, Struyf F, Labajos-Manzanares MT, Fernandez-Sanchez M, Luque-Suarez A.

BMC Musculoskelet Disord. 2017 Apr 4;18(1):136. doi: 10.1186/s12891-017-1498-0.

21.

Does the acromiohumeral distance matter in chronic rotator cuff related shoulder pain?

Navarro-Ledesma S, Struyf F, Labajos-Manzanares MT, Fernandez-Sanchez M, Morales-Asencio JM, Luque-Suarez A.

Musculoskelet Sci Pract. 2017 Jun;29:38-42. doi: 10.1016/j.msksp.2017.02.011. Epub 2017 Mar 9.

PMID:
28315580
22.

Influence of psychological factors on the prognosis of chronic shoulder pain: protocol for a prospective cohort study.

Martinez-Calderon J, Struyf F, Meeus M, Morales-Ascencio JM, Luque-Suarez A.

BMJ Open. 2017 Mar 6;7(3):e012822. doi: 10.1136/bmjopen-2016-012822.

23.

The reliability of physical examination tests for the clinical assessment of scapular dyskinesis in subjects with shoulder complaints: A systematic review.

Lange T, Struyf F, Schmitt J, Lützner J, Kopkow C.

Phys Ther Sport. 2017 Jul;26:64-89. doi: 10.1016/j.ptsp.2016.10.006. Epub 2016 Nov 3. Review.

PMID:
28237770
24.

Musculoskeletal dysfunctions associated with swimmers' shoulder.

Struyf F, Tate A, Kuppens K, Feijen S, Michener LA.

Br J Sports Med. 2017 May;51(10):775-780. doi: 10.1136/bjsports-2016-096847. Epub 2017 Feb 11. Review.

PMID:
28189997
25.

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials.

Tota JE, Struyf F, Merikukka M, Gonzalez P, Kreimer AR, Bi D, Castellsagué X, de Carvalho NS, Garland SM, Harper DM, Karkada N, Peters K, Pope WAJ, Porras C, Quint W, Rodriguez AC, Schiffman M, Schussler J, Skinner SR, Teixeira JC, Wheeler CM, Herrero R, Hildesheim A, Lehtinen M; Costa Rica Vaccine Trial and the PATRICIA study groups.

J Natl Cancer Inst. 2017 Jan 28;109(7). doi: 10.1093/jnci/djw300. Print 2017 Jan.

26.

Letter to the Editor in response to O.M. Bautista, A. Luxembourg. Deconstructing the measure of vaccine efficacy against disease irrespective of HPV in HPV vaccine clinical trials. Contemporary Clinical Trials 47 (2016) 254-258.

Folschweiller N, Berlaimont V, Skinner SR, Wheeler CM, Karkada N, Struyf F, Ryser M.

Contemp Clin Trials. 2017 Mar;54:106-107. doi: 10.1016/j.cct.2016.12.022. Epub 2016 Dec 26. No abstract available.

PMID:
28034686
27.

The safety of Cervarix? - Authors' reply.

Wheeler CM, Struyf F; HPV-015 study group.

Lancet Infect Dis. 2017 Jan;17(1):20-21. doi: 10.1016/S1473-3099(16)30540-0. No abstract available.

PMID:
27998562
28.

Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trial.

Zhu FC, Hu SY, Hong Y, Hu YM, Zhang X, Zhang YJ, Pan QJ, Zhang WH, Zhao FH, Zhang CF, Yang X, Yu JX, Zhu J, Zhu Y, Chen F, Zhang Q, Wang H, Wang C, Bi J, Xue S, Shen L, Zhang YS, He Y, Tang H, Karkada N, Suryakiran P, Bi D, Struyf F.

Cancer Med. 2017 Jan;6(1):12-25. doi: 10.1002/cam4.869. Epub 2016 Dec 20.

29.

Inter-rater reliability of shoulder measurements in middle-aged women.

De Groef A, Van Kampen M, Vervloesem N, Clabau E, Christiaens MR, Neven P, Geraerts I, Struyf F, Devoogdt N.

Physiotherapy. 2017 Jun;103(2):222-230. doi: 10.1016/j.physio.2016.07.002. Epub 2016 Jul 20.

PMID:
27908458
30.

Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial.

Lehtinen M, Eriksson T, Apter D, Hokkanen M, Natunen K, Paavonen J, Pukkala E, Angelo MG, Zima J, David MP, Datta S, Bi D, Struyf F, Dubin G.

Hum Vaccin Immunother. 2016 Dec;12(12):3177-3185. doi: 10.1080/21645515.2016.1183847.

31.

Central Pain Processing in Patients with Shoulder Pain: A Review of the Literature.

Noten S, Struyf F, Lluch E, D'Hoore M, Van Looveren E, Meeus M.

Pain Pract. 2017 Feb;17(2):267-280. doi: 10.1111/papr.12502. Epub 2016 Oct 14. Review.

PMID:
27739242
32.

Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial.

Garland SM, Paavonen J, Jaisamrarn U, Naud P, Salmerón J, Chow SN, Apter D, Castellsagué X, Teixeira JC, Skinner SR, Hedrick J, Limson G, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Germar MJ, Peters K, Del Rosario-Raymundo MR, Catteau G, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Int J Cancer. 2016 Dec 15;139(12):2812-2826. doi: 10.1002/ijc.30391. Epub 2016 Sep 9.

33.

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.

Wheeler CM, Skinner SR, Del Rosario-Raymundo MR, Garland SM, Chatterjee A, Lazcano-Ponce E, Salmerón J, McNeil S, Stapleton JT, Bouchard C, Martens MG, Money DM, Quek SC, Romanowski B, Vallejos CS, Ter Harmsel B, Prilepskaya V, Fong KL, Kitchener H, Minkina G, Lim YKT, Stoney T, Chakhtoura N, Cruickshank ME, Savicheva A, da Silva DP, Ferguson M, Molijn AC, Quint WGV, Hardt K, Descamps D, Suryakiran PV, Karkada N, Geeraerts B, Dubin G, Struyf F; VIVIANE Study Group.

Lancet Infect Dis. 2016 Oct;16(10):1154-1168. doi: 10.1016/S1473-3099(16)30120-7. Epub 2016 Jun 28.

PMID:
27373900
34.

Clinical outcomes of a scapular-focused treatment in patients with subacromial pain syndrome: a systematic review.

Reijneveld EA, Noten S, Michener LA, Cools A, Struyf F.

Br J Sports Med. 2017 Mar;51(5):436-441. doi: 10.1136/bjsports-2015-095460. Epub 2016 Jun 1. Review.

PMID:
27251897
35.

Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9-14 Years Versus a 3-Dose Regimen in Women Aged 15-25 Years.

Puthanakit T, Huang LM, Chiu CH, Tang RB, Schwarz TF, Esposito S, Frenette L, Giaquinto C, McNeil S, Rheault P, Durando P, Horn M, Klar M, Poncelet S, De Simoni S, Friel D, De Muynck B, Suryakiran PV, Hezareh M, Descamps D, Thomas F, Struyf F.

J Infect Dis. 2016 Aug 15;214(4):525-36. doi: 10.1093/infdis/jiw036. Epub 2016 Feb 3.

36.

Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases.

Skinner SR, Apter D, De Carvalho N, Harper DM, Konno R, Paavonen J, Romanowski B, Roteli-Martins C, Burlet N, Mihalyi A, Struyf F.

Expert Rev Vaccines. 2016;15(3):367-87. doi: 10.1586/14760584.2016.1124763. Review.

PMID:
26902666
37.

Exercise- and Stress-Induced Hypoalgesia in Musicians with and without Shoulder Pain: A Randomized Controlled Crossover Study.

Kuppens K, Struyf F, Nijs J, Cras P, Fransen E, Hermans L, Meeus M, Roussel N.

Pain Physician. 2016 Feb;19(2):59-68.

38.

A Multivariable Prediction Model for the Chronification of Non-traumatic Shoulder Pain: A Systematic Review.

Struyf F, Geraets J, Noten S, Meeus M, Nijs J.

Pain Physician. 2016 Feb;19(2):1-10. Review.

39.

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.

Skinner SR, Wheeler CM, Romanowski B, Castellsagué X, Lazcano-Ponce E, Del Rosario-Raymundo MR, Vallejos C, Minkina G, Pereira Da Silva D, McNeil S, Prilepskaya V, Gogotadze I, Money D, Garland SM, Romanenko V, Harper DM, Levin MJ, Chatterjee A, Geeraerts B, Struyf F, Dubin G, Bozonnat MC, Rosillon D, Baril L; VIVIANE Study Group.

Int J Cancer. 2016 May 15;138(10):2428-38. doi: 10.1002/ijc.29971.

40.

Prevalence, Incidence, Localization, and Pathophysiology of Myofascial Trigger Points in Patients With Spinal Pain: A Systematic Literature Review.

Lluch E, Nijs J, De Kooning M, Van Dyck D, Vanderstraeten R, Struyf F, Roussel NA.

J Manipulative Physiol Ther. 2015 Oct;38(8):587-600. doi: 10.1016/j.jmpt.2015.08.004. Epub 2015 Sep 19. Review.

PMID:
26387860
41.

Fewer than three doses of HPV vaccine - Authors' reply.

Kreimer AR, Struyf F, Hildesheim A, David MP, Wheeler CM; all authors of the manuscript.

Lancet Oncol. 2015 Sep;16(9):e424-e425. doi: 10.1016/S1470-2045(15)00196-5. No abstract available.

PMID:
26370346
42.

Endogenous pain inhibition is unrelated to autonomic responses in acute whiplash-associated disorders.

De Kooning M, Daenen L, Roussel N, Cras P, Buyl R, Ickmans K, Struyf F, Nijs J.

J Rehabil Res Dev. 2015;52(4):431-40. doi: 10.1682/JRRD.2014.06.0154.

43.

Efficacy of Different Types of Mobilization Techniques in Patients With Primary Adhesive Capsulitis of the Shoulder: A Systematic Review.

Noten S, Meeus M, Stassijns G, Van Glabbeek F, Verborgt O, Struyf F.

Arch Phys Med Rehabil. 2016 May;97(5):815-25. doi: 10.1016/j.apmr.2015.07.025. Epub 2015 Aug 15. Review.

PMID:
26284892
44.

Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study.

Romanowski B, Schwarz TF, Ferguson L, Peters K, Dionne M, Behre U, Schulze K, Hillemanns P, Suryakiran P, Thomas F, Struyf F.

Hum Vaccin Immunother. 2016;12(1):20-9. doi: 10.1080/21645515.2015.1065363. Epub 2015 Jul 15.

45.

A 9-Valent HPV Vaccine in Women.

Mihalyi A, Ryser M, Struyf F.

N Engl J Med. 2015 Jun 25;372(26):2567. doi: 10.1056/NEJMc1504359. No abstract available.

PMID:
26107061
46.

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

Kreimer AR, Struyf F, Del Rosario-Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David MP, Wheeler CM; Costa Rica Vaccine Trial Study Group Authors, González P, Jiménez S, Lowy DR, Pinto LA, Porras C, Rodriguez AC, Safaeian M, Schiffman M, Schiller JT, Schussler J, Sherman ME; PATRICIA Study Group Authors, Bosch FX, Castellsague X, Chatterjee A, Chow SN, Descamps D, Diaz-Mitoma F, Dubin G, Germar MJ, Harper DM, Lewis DJ, Limson G, Naud P, Peters K, Poppe WA, Ramjattan B, Romanowski B, Salmeron J, Schwarz TF, Teixeira JC, Tjalma WA; HPV PATRICIA Principal Investigators/Co-Principal Investigator Collaborators; GSK Vaccines Clinical Study Support Group.

Lancet Oncol. 2015 Jul;16(7):775-86. doi: 10.1016/S1470-2045(15)00047-9. Epub 2015 Jun 9.

47.

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial.

Leung TF, Liu AP, Lim FS, Thollot F, Oh HM, Lee BW, Rombo L, Tan NC, Rouzier R, Friel D, De Muynck B, De Simoni S, Suryakiran P, Hezareh M, Folschweiller N, Thomas F, Struyf F.

Hum Vaccin Immunother. 2015;11(7):1689-702. doi: 10.1080/21645515.2015.1050570.

48.

Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.

Apter D, Wheeler CM, Paavonen J, Castellsagué X, Garland SM, Skinner SR, Naud P, Salmerón J, Chow SN, Kitchener HC, Teixeira JC, Jaisamrarn U, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Mindel A, de Sutter P, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Clin Vaccine Immunol. 2015 Apr;22(4):361-73. doi: 10.1128/CVI.00591-14. Epub 2015 Feb 4.

49.

Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial.

Lehtinen M, Apter D, Baussano I, Eriksson T, Natunen K, Paavonen J, Vänskä S, Bi D, David MP, Datta S, Struyf F, Jenkins D, Pukkala E, Garnett G, Dubin G.

Vaccine. 2015 Mar 3;33(10):1284-90. doi: 10.1016/j.vaccine.2014.12.019. Epub 2015 Jan 12.

50.

Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.

Struyf F, Colau B, Wheeler CM, Naud P, Garland S, Quint W, Chow SN, Salmerón J, Lehtinen M, Del Rosario-Raymundo MR, Paavonen J, Teixeira JC, Germar MJ, Peters K, Skinner SR, Limson G, Castellsagué X, Poppe WA, Ramjattan B, Klein TD, Schwarz TF, Chatterjee A, Tjalma WA, Diaz-Mitoma F, Lewis DJ, Harper DM, Molijn A, van Doorn LJ, David MP, Dubin G; HPV PATRICIA Study Group.

Clin Vaccine Immunol. 2015 Feb;22(2):235-44. doi: 10.1128/CVI.00457-14. Epub 2014 Dec 24.

Supplemental Content

Loading ...
Support Center